Domov › Sladkorna bolezen tipa 2 › Texas

Klinične študije za Sladkorna bolezen tipa 2 v Texas

58 študij za Sladkorna bolezen tipa 2 išče udeležence na lokacijah v Texas.

Mesta v Texas

Uradno besedilo študije (angleško)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Houston Methodist, Houston
Baylor Scott & White, Temple

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06906640

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Baylor Scott & White, Temple

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06906627

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Horizon Clinical Research Group, Cypress
Cardiovascular Specialists of Willowbrook, Houston
Texas Cardiology Associates of Houston, Kingwood
in še 2

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Amarillo Med Spec LLP, Amarillo
Texas Diabetes & Endocrinology, Austin
North Texas Endocrine Center, Dallas
in še 6

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Pinnacle Clinical Research - Austin, Austin
South Texas Research Institute - Brownsville, Brownsville
Headlands Research - Brownsville, Brownsville
in še 25

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Texas Diabetes and Endocrinology - Central Austin, Austin
South Texas Research Institute - Brownsville, Brownsville
Privia Medical Group Gulf Coast, PLLC, Conroe
in še 10

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07754461

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

University of Texas Southwestern Medical Center, Dallas
Parkland Health & Hospital System (PHHS), Dallas
Baylor Scott and White - Health System, Dallas

Vključevanje udeležencev

Vse starosti · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06593327

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Hendrick Health, Abilene
Gadolin Research, Beaumont
CardioVoyage, LLC, Greenville
in še 10

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 55 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06112418

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Endeavor Clinical Trials, San Antonio

Vključevanje udeležencevFaza 1

Starost 18–65 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07399678

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

PlanIt Research, LLC (Monitoring Room), Houston
PlanIt Research, LLC, Houston
VIP Trials, San Antonio

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Houston

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

IMA Clinical Research Austin, Austin
Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
Velocity Clinical Research, Dallas, Dallas
in še 5

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, DeSoto
Research Site, El Paso
Research Site, Houston
in še 5

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

The University of Texas Health Science Center at San Antonio, San Antonio

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 18–65 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT02969798

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Austin
AURORA-2 Clinical Site, Brownsville
AURORA-2 Clinical Site, DeSoto
in še 10

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

M3 Wake Research - Dallas, Dallas
University of Texas Southwestern Medical Center, Dallas
SMS Clinical Research, LLC - 400 W. Kearney St, Mesquite
in še 3

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Headlands Research Brownsville, Brownsville
Velocity Clinical Research, Dallas
South Texas Research Institute - Edinburg, Edinburg
in še 5

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Juno Research, Houston
Southern Endocrinology Associates, Mesquite
Texas Diabetes & Endocrinology, P.A., Round Rock
in še 2

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

University of Texas Southwestern Medical Center, Dallas
JCCT- Juno NW Houston, Houston
Consano Clinical Research, LLC, Shavano Park

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Arlington Nephrology, PLLC., Arlington
M3 Wake Research Dallas - Internal Medicine, Dallas
Revival Research Institute, LLC, Dallas
in še 10

Vključevanje udeležencevFaza 2

Starost 18–80 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

IMA Clinical Research, Austin
Private Practice - Dr. Laila A. Hassan, Houston
Radiance Clinical Research, Lampasas
in še 3

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Research Site, Dallas
Research Site, Houston
Research Site, Houston
in še 6

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Velocity Clinical Research, Austin, Austin
Velocity Clinical Research - Dallas, Dallas
Juno Research, LLC, Houston
in še 8

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Amir Ali Hassan, MD, PA, Houston
Consano Clinical Research, LLC, Shavano Park

Vključevanje udeležencevFaza 3

Starost 10–18 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07282613

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Mercy Family Clinic, Dallas
Velocity Clinical Research, Dallas, Dallas
Biopharma Informatic, LLC, Houston
in še 5

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Elligo Clinical Research Center, Austin
Johnson County Clinical Trials Juno Bellaire, Bellaire
Osvaldo A Brusco MD PA, Corpus Christi
in še 2

Vključevanje udeležencevFaza 3

Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Research Site, San Antonio

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

PharmaTex Research, Amarillo
Pinnacle Clinical Research, Austin
Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe
in še 20

Vključevanje udeležencevFaza 3

Starost 45 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Research Site, Dallas
Research Site, McKinney
Research Site, Paris
in še 1

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662109

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Research Site, Irving

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662044

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

Texas Diabetes & Endocrinology, Austin

Vključevanje udeležencev

Starost 18–80 · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07599982

Quantifying Hepatic Mitochondrial Fluxes in Humans

Texas Diabetes Institute - University Health System, San Antonio
University of Texas Health Science Center at San Antonio, San Antonio

Vključevanje udeležencevFaza 4

Starost 18–80 · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05305287

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

Research Site, San Antonio

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci

Starost 18–75 · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT07024823

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Research Institute of Dallas, Dallas
Texas Childrens Hospital, Houston
UT Health Houston, Houston

Vključevanje udeležencevFaza 3

Starost 10–17 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06739122

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Research Site, Houston
Research Site, Round Rock
Research Site, San Antonio

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT07664553

Polypill for Prevention of Cardiomyopathy

UT Southwestern Medical Center, Dallas

Vključevanje udeležencevFaza 1/2

Starost 18–100 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06143566

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

Baylor College of Medicine, Houston

Vključevanje udeležencev

Starost 14–75 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT07579702

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Texas Diabetes and Endocrinology, Austin
Tekton Research, McKinney
Tekton Research, San Antonio

Vključevanje udeležencev

Starost 18–75 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT07521475

SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes

Brooke Army Medical Center, San Antonio

Vključevanje udeležencev

Starost 18–70 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT07674628

SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia

Texas Diabetes Institute/UH, San Antonio

Vključevanje udeležencevFaza 1

Starost 30–75 · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT07053306

Vir: ClinicalTrials.gov, podatki pridobljeni 4. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.